PBE ETF top 10 holdings are 44.5% of the fund as of Jun 30, 2026
PBE ETF top 10 holdings are 44.5% of the fund as of Jun 30, 2026
$96.56
AUM$379M
TER0.58%
Holdings33
See how much of PBE you already own
PBE ETF top 10 holdings are 44.5% of the fund as of Jun 30, 2026
$96.56
Invesco Biotechnology and Genome ETF
AUM$379M
TER0.58%
Holdings33
See how much of PBE you already own
PBE holds 44.5% of its assets in its 10 largest positions as of Jun 30, 2026. PBE is Invesco Biotechnology and Genome ETF.
PBE ETF Top Holdings
PBE holdings top 10 positions. The top 10 holdings account for 44.5% of the fund, led by Nvaesrtex Pharmaceuticals Inc at 5.2%, Biogen Inc. Com at 5.1%, Amgen Inc. at 4.9%.
PBE portfolio concentration is moderate, with the top 10 representing 44.5% of total assets. The largest sector exposure is Health Care at 92.3%.
PBE sectors provide a detailed breakdown. PBE overlap shows how holdings compare to other funds in your portfolio.








